| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > The Sea Freight Industry is Failing to Meet Its Schedules |
|
Useful Advices - The Sea Freight Industry is Failing to Meet Its Schedules
A recent survey of the reliability of scheduling in the sea freight industry has revealed wo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rrying results. The survey examined sea freight schedules on a worldwide basis. It demonstrated tha ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t over 40% of the world’s cargo carrying ships arrived at their destination at least a day late. In lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. many cases ships arrived in port well over several days late. The survey derived results from an here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe examination of 3,300 ships arriving on 23 east-west and north-south routes. It was part of a quarte d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ly review of the global sea freight industry. Although the survey showed that nearly 60% of all co ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ntainer ships arrived on time, the overall results were not inspiring. 22% of all the container shi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ps arrived a day later than their scheduled arrival date. Moreover, 21% of the ships that were trac nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ked arrived more than one day late. The results from the survey also showed that there were large and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ variations in performance between the different sea freight operators. Between December last ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi year and April this year, on time arrival ranged between 0% and 91%. Chinese sea freight co ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a mpanies were least likely to arrive on time, according to the results of the survey. The implicati dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ons of the results generated by the survey are very concerning to all those working in the sea frei cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ght industry. They show that many companies within the industry do not offer the reliable service t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen hat their customers require. It is true that there are external and uncontrollable factors that ca t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel affect a ship’s schedule. For instance port congestion can impact on arrival times. However, the f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust act that companies’ ability to meet schedules varied considerably even on the same route demonstrat y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products es that these factors are not the main problem. The real problem seems to be that many sea frei . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ght forwarders do not give enough buffer time to external factors in their weekly schedules. In elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip other words, they do not build in time for issues like port congestion and poor weather conditions tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Golf Course Designers - How to Choose an Architect to Design Your Golf Course
|